AWA
LPCN icon

Aaron Wealth Advisors’s Lipocine LPCN Stock Holding History

Aaron Wealth Advisors’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,115
Closed -$11.4K – 260
2023
Q1 		$11.4K Hold
2,115
– – ﹤0.01% 250
2022
Q4 		$13.8K Sell
2,115
-535
-20% -$3.9K ﹤0.01% 244
2022
Q3 		$20K Sell
2,650
-5,882
-69% -$65.7K ﹤0.01% 220
2022
Q2 		$116K Buy
8,532
+1,617
+23% +$25.2K 0.03% 184
2022
Q1 		$85.8M Buy
+6,915
New +$145K 1.19% 18
2021
Q2 		– Sell
-882
Closed -$22K – 163
2021
Q1 		$22K Buy
+882
New +$25.5K 0.01% 151

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aaron Wealth Advisors's LPCN Position: Q2 2023 in Review

Aaron Wealth Advisors sold out of Lipocine (LPCN) in Q2 2023, closing a stake of 2,115 shares — an estimated $11.4K sold.

Aaron Wealth Advisors first reported a position in LPCN in Q1 2021 and held it in 6 quarters. The position peaked at $85.8M in Q1 2022. 24 funds tracked by Wall St. Rank hold LPCN as of Q2 2023.

  • Aaron Wealth Advisors reported no remaining Lipocine position as of Q2 2023 after selling out during the quarter.
  • Aaron Wealth Advisors sold 2,115 Lipocine shares in Q2 2023, an estimated $11.4K.
  • Aaron Wealth Advisors first reported a position in Lipocine in Q1 2021 and held it in 6 quarters.
  • Aaron Wealth Advisors's Lipocine position peaked at $85.8M in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Lipocine as of Q2 2023.

Based on Aaron Wealth Advisors's 13F filing for Q2 2023, filed 26 Jul 2023.